These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 25195064)

  • 21. [Effects of gamma-vinyl GABA per os in 5 cases of hebephreno-catatonic schizophrenia].
    Lambert PA; Chabannnes JP; Cantiniaux P; Schechter PJ; Tell GP
    Encephale; 1983; 9(2):145-9. PubMed ID: 6641616
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of catatonic schizophrenia with lorazepam and aripiprazole.
    Cummings TS; Noordsy DL
    Schizophr Res; 2009 Jul; 112(1-3):194-5. PubMed ID: 19411162
    [No Abstract]   [Full Text] [Related]  

  • 23. The catatonic dilemma.
    Brenner I; Rheuban WJ
    Am J Psychiatry; 1978 Oct; 135(10):1242-3. PubMed ID: 696912
    [No Abstract]   [Full Text] [Related]  

  • 24. Memantine and catatonic schizophrenia.
    Thomas C; Carroll BT; Maley RT; Jayanti K; Koduri A
    Am J Psychiatry; 2005 Mar; 162(3):626. PubMed ID: 15741490
    [No Abstract]   [Full Text] [Related]  

  • 25. Mosé Da Prada: development of an outstanding scientist.
    Pletscher A
    J Neural Transm Suppl; 1998; 52():VII-XII. PubMed ID: 9564600
    [No Abstract]   [Full Text] [Related]  

  • 26. Monoamine oxidase: isoforms and inhibitors in Parkinson's disease and depressive illness.
    Youdim MB; Bakhle YS
    Br J Pharmacol; 2006 Jan; 147 Suppl 1(Suppl 1):S287-96. PubMed ID: 16402116
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adjusting the frequency of continuation and maintenance electroconvulsive therapy to prevent relapse of catatonic schizophrenia in middle-aged and elderly patients who are relapse-prone.
    Suzuki K; Awata S; Takano T; Ebina Y; Shindo T; Harada N; Matsuoka H
    Psychiatry Clin Neurosci; 2006 Aug; 60(4):486-92. PubMed ID: 16884452
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of harmine on dopamine output and metabolism in rat striatum: role of monoamine oxidase-A inhibition.
    Iurlo M; Leone G; Schilström B; Linnér L; Nomikos G; Hertel P; Silvestrini B; Svensson H
    Psychopharmacology (Berl); 2001 Dec; 159(1):98-104. PubMed ID: 11797076
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clozapine monotherapy for catatonic schizophrenia: should clozapine be the treatment of choice, with catatonia rather than psychosis as the main therapeutic index?
    Dursun SM; Hallak JE; Haddad P; Leahy A; Byrne A; Strickland PL; Anderson IM; Zuardi AW; Deakin JF
    J Psychopharmacol; 2005 Jul; 19(4):432-3. PubMed ID: 15983003
    [No Abstract]   [Full Text] [Related]  

  • 30. [Neuroleptic malignant syndrome in catatonic schizophrenia with respiratory insufficiency--an interdisciplinary problem].
    Koberstein B; Balzer K; Eikmeier G; Hager W; Goebell H
    Med Klin (Munich); 1990 Mar; 85 Suppl 1():129-32. PubMed ID: 2342438
    [No Abstract]   [Full Text] [Related]  

  • 31. The discovery and development of rasagiline as a new anti-Parkinson medication.
    Finberg JPM
    J Neural Transm (Vienna); 2020 Feb; 127(2):125-130. PubMed ID: 31974721
    [No Abstract]   [Full Text] [Related]  

  • 32. [Severe hypernatremia within the scope of catatonic schizophrenia].
    Trabert W; von Blohn G; Gawlitza M
    Fortschr Neurol Psychiatr; 1986 Jun; 54(6):196-8. PubMed ID: 2873092
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Lithium in the treatment of periodically occurring catatonic arousal states in schizophrenic patients].
    Weizsäcker M; Wöller W; Tegeler J
    Nervenarzt; 1984 Jul; 55(7):382-4. PubMed ID: 6147768
    [No Abstract]   [Full Text] [Related]  

  • 34. Amineptine treatment of persistent catatonic symptoms in schizophrenia: a controlled study.
    Ungvari GS
    Neuropsychopharmacol Hung; 2010 Dec; 12(4):463-7. PubMed ID: 21220791
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment-resistant catatonic stupor and combined lithium-neuroleptic therapy: a case report.
    Climo LH
    J Clin Psychopharmacol; 1985 Jun; 5(3):166-70. PubMed ID: 3923060
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Secondary enuresis & body dysmorphic disorder in a caucasian male with catatonic schizophrenia: a case report.
    Zaman N; Karale M; Agius M
    Psychiatr Danub; 2010 Nov; 22 Suppl 1():S53-5. PubMed ID: 21057404
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diazepam for catatonia.
    McEvoy JP; Lohr JB
    Am J Psychiatry; 1984 Feb; 141(2):284-5. PubMed ID: 6691497
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of monoamine oxidase inhibition on amphetamine-evoked changes in dopamine receptor availability in the living pig: a dual tracer PET study with [11C]harmine and [11C]raclopride.
    Jensen SB; Olsen AK; Pedersen K; Cumming P
    Synapse; 2006 Jun; 59(7):427-34. PubMed ID: 16485265
    [TBL] [Abstract][Full Text] [Related]  

  • 39. beta-Carboline alkaloids in Peganum harmala and inhibition of human monoamine oxidase (MAO).
    Herraiz T; González D; Ancín-Azpilicueta C; Arán VJ; Guillén H
    Food Chem Toxicol; 2010 Mar; 48(3):839-45. PubMed ID: 20036304
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The use of monoamine oxidase inhibitors in schizophrenia.
    Brenner R; Shopsin B
    Biol Psychiatry; 1980 Aug; 15(4):633-47. PubMed ID: 7397294
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.